Asthma and COPD Drugs Market was worth $32.99 billion in 2020 and is on track to reach $52.05 billio
The Asthma and COPD Drugs Market has been a key player in the global pharmaceutical industry for years, providing much-needed relief to millions of individuals who suffer from chronic respiratory diseases. These two prevalent conditions, asthma and chronic obstructive pulmonary disease (COPD), have spurred innovatio...
Boehringer Ingelheim International Gmb Teva Pharmaceutical Industries Ltd Vectura Group Plc Roche Ltd Glaxosmithkline Plc Astrazeneca Plc
Source: pharmiweb.com